Teladoc (TDOC) President Bliss Kelly Sells 7,357 Shares

What Happened

• Bliss Kelly, President, U.S. Group Health at Teladoc Health (TDOC), had restricted and performance stock units convert to common stock on Sept 1, 2026 (derivative conversions). The filing shows conversions of 4,859, 9,152 and 1,300 shares (total 15,311 shares) from RSUs/PSUs. A portion of those shares were withheld/surrendered for tax purposes, and on Sept 2, 2026 she sold 7,357 shares in the open market at $6.30 per share, generating proceeds of $46,356.

Key Details

• Transaction dates: conversions on 2026-09-01; open-market sale on 2026-09-02; Form 4 filed 2026-09-03 (appears timely).
• Sale detail: 7,357 shares sold at $6.30 = $46,356 total proceeds.
• Derivative activity: 15,311 shares converted from RSUs/PSUs on 2026-09-01 (codes M — exercise/conversion); an equal number of shares were listed as disposed at $0 in connection with the conversion (tax withholding).
• Footnotes: F1/F2 confirm RSUs and PSUs convert one-for-one to common stock; F3 states shares were sold to cover tax withholding on vesting; F4–F6 describe the original grants and vesting schedules.
• Shares owned after the transactions: not specified in the filing.

Context

• These were not open-market purchases but vesting/conversion of equity awards followed by share withholding/sale to cover taxes and a separate small open-market sale — a common, routine action tied to compensation vesting rather than an outright investment decision. The derivative entries reflect conversion/vesting of RSUs/PSUs (not a cash option exercise), with some shares used to satisfy tax withholding.